NeuroSense Therapeutics News

Maxim Group Maintains NeuroSense Therapeutics(NRSN.US) With Buy Rating, Maintains Target Price $3

Futu NewsOct 12 22:31

Maxim Group Keeps Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)

TipRanksOct 12 22:18

Buy Rating Affirmed on Neurosense Therapeutics Following Promising PrimeC Trial Results

TipRanksJul 3 22:59

Buy Rating on Neurosense Therapeutics Backed by Promising ALS Treatment Results

TipRanksMay 25 00:45

Maxim Group Reaffirms Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)

TipRanksAug 18, 2023 03:15

Alliance Global Partners Initiates Coverage On NeuroSense Therapeutics With Buy Rating, Announces Price Target of $7.5

BenzingaJul 17, 2023 22:25

NeuroSense Therapeutics Analyst Ratings

BenzingaJul 17, 2023 22:24

Maxim Group Keeps Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)

TipRanksJun 15, 2023 03:15

Neurosense Therapeutics Ltd. (NRSN) Gets a Buy From Maxim Group

TipRanksJun 3, 2023 23:45

Analysts Are Bullish on These Healthcare Stocks: UniQure (QURE), Neurosense Therapeutics Ltd. (NRSN)

TipRanksMay 16, 2023 22:50

Analysts' Opinions Are Mixed on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), Qiagen (QGEN) and Neurosense Therapeutics Ltd. (NRSN)

TipRanksMay 4, 2023 22:51

Maxim Group Reaffirms Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)

TipRanksMar 25, 2023 22:36

Neurosense Therapeutics Ltd. (NRSN) Gets a Buy From Maxim Group

TipRanksFeb 8, 2023 20:40

Maxim Group Sticks to Its Buy Rating for Neurosense Therapeutics Ltd. (NRSN)

TipRanksJan 21, 2023 01:10

Maxim Group Sticks to Their Buy Rating for Neurosense Therapeutics Ltd. (NRSN)

TipRanksDec 3, 2022 01:35